Mammalian Polyclonal IgG Antibody Global Market Report 2023: Growing Prevalence of Standard Laboratory Tests Bolsters Sector - ResearchAndMarkets.com
Retrieved on:
Thursday, March 16, 2023
Biotechnology, Science, Health, Research, Neoplasm, Syphilis, Prevalence, Antibody, Immunoelectrophoresis, Organization, Epitope, Immunoglobulin G, Conditional sentence, University, Human, COVID-19, IHC, AIDS, Flow cytometry, Immunohistochemistry, Cancer, Hospital, CVD, Government, Anemia, Growth, GSK plc, Viral, Government agency, Acceleration, ELISA, Lyme disease, Mouse, Plasma, Application, Biomarker, Agilent Technologies, USD, Region, Diagnosis, CDC, Western blot, Rabbit, Serum, Autoimmunity, SARS-CoV-2, State, Investment, GenScript Biotech, Animal, Disease, Chip, Incidence, Diabetes, Fine chemical, Pharmaceutical industry, Vaccine, Immunoprecipitation
The "Mammalian Polyclonal IgG Antibody Market by Type, by Product, by Application, by End-user, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Mammalian Polyclonal IgG Antibody Market by Type, by Product, by Application, by End-user, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
- The mammalian polyclonal IgG antibody market size is estimated to be USD 1,347.4 million in 2022 and is expected to witness a CAGR of 5.28% during the forecast period 2023-2033.
- Furthermore, growing prevalence of standard laboratory tests, government investment, acceleration in institutional and academic research, and affordability of supporting equipment and technology are other factors supporting the market growth.
- Growing prevalence of standard laboratory tests such as microarray assays, western blot analysis, immunohistochemical, and cell imaging is predicted to propel the mammalian polyclonal IgG antibody market growth during the forecast period.